Dr. Victor Velculescu, CEO and founder of Delfi Diagnostics. Baltimore life sciences company Delfi Diagnostics is $225 million closer to bringing its blood test for early detection of cancer to the ...
CHICAGO — Delfi Diagnostics, a company seeking to develop liquid biopsy tests to help screen for lung cancer, published a scientific paper on Monday describing key aspects of the test and unveiled the ...
It didn’t take Delfi Diagnostics long after its 2019 founding to hit the coveted nine-digit funding mark: It reached that milestone in early 2021 with the close of its $100 million series A. Less than ...
DFJ Growth's Justin Kao Joins Delfi Board of Directors BALTIMORE and PALO ALTO, Calif., July 18, 2022 /PRNewswire/ -- Delfi Diagnostics, Inc., a pioneering developer of a new class of high-performance ...
Return On Capital Employed (ROCE): What Is It? Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested ...
DELFI Diagnostics has clinically validated FirstLook Lung, its blood test designed to improve early detection of lung cancer, which remains the leading cause of cancer deaths in the United States. At ...
NEW YORK, December 04, 2025--(BUSINESS WIRE)--As financial institutions continue to navigate increasing uncertainty, Delfi, an AI-native risk management platform, and CFO Consulting Partners LLC ...
Provider of Accessible Blood-Based Tests for Cancer Detection Highlights Results of Clinical Trial in Preeminent Peer-Reviewed Publication The company currently has an active pipeline of biotech and ...
Wee Kuang Tay, an analyst from CGS-CIMB, reiterated the Buy rating on Delfi (PEFDF – Research Report). The associated price target is S$1.10. Wee Kuang Tay has given his Buy rating due to a ...
The Remington-based startup was founded by Johns Hopkins oncology professor Dr. Victor Velculescu, who also cofounded Canton’s Personal Genome Diagnostics. Inside FastForward 1812, an East ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results